1. World Health Organization. WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. Geneva: World Health Organization; 2018. https://www.who.int/publications/i/item/9789241550390. Accessed 14 Jun 2022.
2. Martindale. Analgesics, anti-inflammatory drugs and antipyretics. Morphine. In: Brayfield A, editor. Martindale: the complete drug reference. 39th ed. London: Pharmaceutical Press; 2017. p. 93–7.
3. US FDA, Center for Drug Evaluation and Research. Morphine Sulfate Roxane Clinical pharmacology and biopharmaceutics reviews. Application number NDA 22-195 and NDA 22-207. Silver Spring, MD: US FDA; 2007.
4. Guo BB, Zhang YQ, Wang SF, Ding JS, Zhou WH. The pharmacokinetics of morphine and codeine in human plasma and urine after oral administration of Qiangli Pipa Syrup. J Forensic Sci. 2018;63(4):1221–8. https://doi.org/10.1111/1556-4029.13696.
5. Webster L, Owen J, Darling I, Richards P, Kelen R, Stern W (eds). Single-dose and steady-state pharmacokinetics of moxduo™, A dual-opioid formulation containing a fixed ratio of morphine and oxycodone [poster]. In: 29th Annual Meeting of the American Pain Society, 6–8 May 2010: Baltimore, MD.